Electronic Alert System for Improving Thromboprophylaxis in Hospitalized Medical Patients

Venous Thromboembolism Clinical Trial

Official title:

Electronic Alert System Combined With a Risk Score Calculation Tool for Improving Appropriate Thromboprophylaxis in Hospitalized Medical Patients: a Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03124017
• Other study ID #: 159/14
• Status: Completed
• Phase: N/A
• First received: April 18, 2017
• Last updated: April 18, 2017
• Start date: March 2015
• Est. completion date: June 2016

Study information

• Verified date: April 2017
• Source: University Hospital Inselspital, Berne
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigators aim to investigate whether a computer-based alert system in the electronic patient chart and order entry system using the Geneva Risk Score as clinical decision support tool to estimate the risk of venous thromboembolism improves the rate of appropriate thromboprophylaxis among hospitalized medical patients.

Description:

The use of thromboprophylaxis among acutely ill hospitalized medical patients remains inconsistent. The present study aims to improve the use of appropriate thromboprophylaxis by implementing a computer-based alert system combined with a Geneva Risk Score calculation tool in the electronic patient chart and order entry system. Consecutive acutely ill medical patients without indication for therapeutic anticoagulation or ongoing therapeutic anticoagulant treatment admitted to the medical wards of the University Hospital Bern, Switzerland, will be randomized in a 1:1 fashion to the alert group in which an alert and the Geneva Risk Score calculation tool will be issued in the electronic patient chart or to the control group in which no alert will be issued. The primary endpoint is the rate of appropriate thromboprophylaxis during hospital stay.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1756
• Est. completion date: June 2016
• Est. primary completion date: March 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Acutely ill medical patients admitted to medical wards

Exclusion Criteria:

• Indication for therapeutic anticoagulation or ongoing therapeutic anticoagulant treatment

Related Conditions & MeSH terms

• Thromboembolism
• Venous Thromboembolism

Intervention

Other:
• Electronic alert and the Geneva Risk Score calculation tool issued in the electronic patient chart

Locations

Country	Name	City	State
Switzerland	Swiss Cardiovascular Center, Inselspital, University of Bern	Bern

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital Inselspital, Berne

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of appropriate thromboprophylaxis		During hospital stay (expected average duration of 1 week)
Secondary	Use of the Geneva Risk Score calculation tool by the physician in charge		During hospital stay (expected average duration of 1 week)
Secondary	Rate of correct calculation of the Geneva Risk Score through the calculation tool by the physician in charge		During hospital stay (expected average duration of 1 week)